Steven Cohen’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-123,100
Closed -$4.34M – 4130
2025
Q3
$4.34M Sell
123,100
-6,000
-5% -$217K 0.01% 1119
2025
Q2
$4.65M Hold
129,100
– – 0.01% 999
2025
Q1
$4.02M Buy
+129,100
New +$4.09M 0.01% 1004

Other funds holding RPRX

Steven Cohen's RPRX Position: Q3 2026 in Review

Steven Cohen increased its Royalty Pharma (RPRX) stake by 954% in Q3 2026, buying an estimated $60M and bringing the position to 1,123,256 shares worth $65.6M. The position accounts for 0.07% of the portfolio, ranked #336.

Steven Cohen first reported a position in RPRX in Q3 2021 and has held it in 14 quarters since. The position peaked at $73.7M in Q1 2022. 697 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

  • Steven Cohen held 1,123,256 shares of Royalty Pharma worth $65.6M as of Q3 2026.
  • Steven Cohen bought 1,016,707 Royalty Pharma shares in Q3 2026, an estimated $60M.
  • Royalty Pharma made up 0.07% of Steven Cohen's portfolio in Q3 2026, its #336 holding.
  • Steven Cohen first reported a position in Royalty Pharma in Q3 2021 and has held it in 14 quarters since.
  • Steven Cohen's Royalty Pharma position peaked at $73.7M in Q1 2022.
  • 697 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.